Results 51 to 60 of about 4,187 (224)

Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity

open access: yesVirology Journal, 2023
Since SARS-CoV-2 was first reported in late 2019, multiple variations of the original virus have emerged. Each variant harbors accumulations of mutations, particularly within the spike glycoprotein, that are associated with increased viral ...
Saina Beitari   +6 more
doaj   +1 more source

Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection

open access: yesFrontiers in Immunology, 2023
The first exposure to influenza is presumed to shape the B-cell antibody repertoire, leading to preferential enhancement of the initially formed responses during subsequent exposure to viral variants.
Petra Mooij   +23 more
doaj   +1 more source

Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields

open access: yesViruses, 2023
Mutations and the glycosylation of epitopes can convert immunogenic epitopes into non-immunogenic ones via natural selection or evolutionary pressure, thereby decreasing their sensitivity to neutralizing antibodies.
Leili Baghaie   +5 more
doaj   +1 more source

The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination

open access: yesVaccines, 2018
The first exposure to influenza is thought to impact subsequent immune responses later in life. The consequences of this can be seen during influenza epidemics and pandemics with differences in morbidity and mortality for different birth cohorts.
Ewan P. Plant   +5 more
doaj   +1 more source

HLA, Immune Response, and Susceptibility to COVID-19

open access: yesFrontiers in Immunology, 2021
The severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) that appeared in December 2019 has precipitated the global pandemic Coronavirus Disease 2019 (COVID-19).
Fataneh Tavasolian   +9 more
doaj   +1 more source

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

open access: yesCell Reports Medicine, 2021
Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy.
Daniel J. Sheward   +12 more
doaj   +1 more source

Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains

open access: yesmBio, 2021
Prime-boost vaccinations of humans with different H5 strains have generated broadly protective antibody levels. However, the effect of an individual’s H5 exposure history on antibody responses to subsequent H5 vaccination is poorly understood.
Jiong Wang   +7 more
doaj   +1 more source

Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections

open access: yesViruses, 2019
The influenza virus-host interaction is a classic arms race. The recurrent and evolving nature of the influenza virus family allows a single host to be infected several times.
Magen Ellen Francis   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy